by Karl Denninger
The governments — states, localities, and probably the CDC — already know if HCQ works as a prophylaxis.
They likely know it within statistical significance too.
That is, not a guess. A fact.
Lupus and RA patients take it routinely as a maintenance drug. There are millions of them. We know how many there are and how many are taking the drug. It’s available data.
Those are both autoimmune diseases and thus those people are at high risk too. If they’re getting it they should be dying from it at the typical 5-50x rate of the general population that is associated with having one or more of the identified high-risk conditions.